Shanghai Hi-Tech Park Acquires Stake In Medical Devices Company MicroPort As Part Of Overhaul Of Shanghai Pharmaceutical Industry
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Shanghai Zhangjiang Hi-Tech Park Development announced June 27 the company will pay $85.35 million to acquire a 24.4 percent stake in MicroPort Scientific
You may also be interested in...
Shanghai Pharmaceutical (Group) Begins Restructuring
Last year, Shanghai Industrial Investment acquired 60 percent stake in Shanghai Pharmaceutical (Group) and began a series of preparations for reorganization (PharmAsia News, June 30, 2008). In April, SII announced the restructuring of SPG and promised the release of a preliminary plan by June 30. However, SPG has already started its internal restructuring that will gradually transform its current 20-plus subsidiaries to independent corporate entities; one was officially declared as one this month. The move aims to make each firm a market player and raise operational efficiency. (Click here for more - Chinese Language)
MNCs Applaud Shanghai Zhangjiang Hi-tech Park Pilot Program To Accelerate Biomaterial Imports
SHANGHAI - Ten research centers in Shanghai Zhangjiang Hi-tech Park have passed inspections by the General Administration of Quality Supervision, Inspection and Quarantine for the first round of a pilot program aimed at simplifying import procedures and at shortening the time it takes to approve imported biomaterial
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).